A variety of DP4-restricted antigenic peptides that can induce CD4+ T-cell responses in association with cancer and infection have been identified (http://archive.cancerimmunity.org/peptidedatabase/tumorspecific.htm)20, 42, 43, 44. Here, TFDP3 is linked to cancer.